These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Antibody-directed enzyme prodrug therapy (ADEPT): a review. Springer CJ; Niculescu-Duvaz I Adv Drug Deliv Rev; 1997 Jul; 26(2-3):151-172. PubMed ID: 10837540 [TBL] [Abstract][Full Text] [Related]
23. Evaluating the abilities of diverse nitroaromatic prodrug metabolites to exit a model Gram negative vector for bacterial-directed enzyme-prodrug therapy. Chan-Hyams JVE; Copp JN; Smaill JB; Patterson AV; Ackerley DF Biochem Pharmacol; 2018 Dec; 158():192-200. PubMed ID: 30352235 [TBL] [Abstract][Full Text] [Related]
24. Virus-directed enzyme prodrug therapy using CB1954. Grove JI; Searle PF; Weedon SJ; Green NK; McNeish IA; Kerr DJ Anticancer Drug Des; 1999 Dec; 14(6):461-72. PubMed ID: 10834268 [TBL] [Abstract][Full Text] [Related]
25. The design of selectively-activated anti-cancer prodrugs for use in antibody-directed and gene-directed enzyme-prodrug therapies. Denny WA; Wilson WR J Pharm Pharmacol; 1998 Apr; 50(4):387-94. PubMed ID: 9625483 [TBL] [Abstract][Full Text] [Related]
29. Antibody directed enzyme prodrug therapy (ADEPT) and related approaches for anticancer therapy. Jung M Mini Rev Med Chem; 2001 Nov; 1(4):399-407. PubMed ID: 12369965 [TBL] [Abstract][Full Text] [Related]
30. Selective activation of anthracycline prodrugs for use in conjunction with ADEPT. HariKrishna D; Rao AR; Krishna DR Drug News Perspect; 2003 Jun; 16(5):309-18. PubMed ID: 12942162 [TBL] [Abstract][Full Text] [Related]
31. Synthesis and evaluation of nitroheterocyclic carbamate prodrugs for use with nitroreductase-mediated gene-directed enzyme prodrug therapy. Hay MP; Anderson RF; Ferry DM; Wilson WR; Denny WA J Med Chem; 2003 Dec; 46(25):5533-45. PubMed ID: 14640560 [TBL] [Abstract][Full Text] [Related]
32. Dendrimers as Non-Viral Vectors in Gene-Directed Enzyme Prodrug Therapy. Chis AA; Dobrea CM; Rus LL; Frum A; Morgovan C; Butuca A; Totan M; Juncan AM; Gligor FG; Arseniu AM Molecules; 2021 Oct; 26(19):. PubMed ID: 34641519 [TBL] [Abstract][Full Text] [Related]
33. Gene-directed enzyme prodrug therapy: a review of enzyme/prodrug combinations. Niculescu-Duvaz I; Springer CJ Expert Opin Investig Drugs; 1997 Jun; 6(6):685-703. PubMed ID: 15989636 [TBL] [Abstract][Full Text] [Related]
34. Complementation Dependent Enzyme Prodrug Therapy Enables Targeted Activation of Prodrug on HER2-Positive Cancer Cells. Nervig CS; Hatch ST; Owen SC ACS Med Chem Lett; 2022 Nov; 13(11):1769-1775. PubMed ID: 36385932 [TBL] [Abstract][Full Text] [Related]
39. Analysis of antibody-enzyme conjugate clearance by investigation of prodrug and active drug in an ADEPT clinical study. Springer CJ; Poon GK; Sharma SK; Bagshawe KD Cell Biophys; 1994; 24-25():193-207. PubMed ID: 7736524 [TBL] [Abstract][Full Text] [Related]